Guardion Health Sciences, Inc. (GHSI)

NASDAQ: GHSI · IEX Real-Time Price · USD
8.07
+0.15 (1.89%)
At close: Apr 17, 2024, 4:00 PM
7.85
-0.22 (-2.73%)
After-hours: Apr 17, 2024, 5:30 PM EDT
1.89%
Market Cap 10.36M
Revenue (ttm) 12.25M
Net Income (ttm) 158,033
Shares Out 1.28M
EPS (ttm) 0.12
PE Ratio 67.25
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,237
Open 7.91
Previous Close 7.92
Day's Range 7.85 - 8.07
52-Week Range 5.01 - 10.75
Beta 0.88
Analysts Hold
Price Target n/a
Earnings Date May 13, 2024

About GHSI

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceuti... [Read more]

Sector Healthcare
IPO Date Apr 5, 2019
Employees 9
Stock Exchange NASDAQ
Ticker Symbol GHSI
Full Company Profile

Financial Performance

Financial Statements

News

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022

19 days ago - GlobeNewsWire

What made Guardion Health stock double on Wednesday?

Guardion Health Sciences Inc (NASDAQ: GHSI) is up nearly 100% this morning after Doctor's Best Inc agreed to buy its Activ Nutritional LLC. Could Guardion Health stock climb any further?

2 months ago - Invezz

Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor's Best Inc.

HOUSTON, TEXAS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) announced today that it has signed an equity purchase agreement to sell it...

2 months ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023

Viactiv ® Generated Net Revenues of Approximately $3.3 Million for the Three Months Ended September 30, 2023, an increase of 27% over the Three Months Ended September 30, 2022

5 months ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023

Viactiv® Product Line Total Revenue Increased Approximately 6% for the Six Months Ended June 30, 2023, as Compared to the Six Months Ended June 30, 2022; Robust Growth in Amazon Sales Channel Demonstr...

8 months ago - GlobeNewsWire

Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer

Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Business Opportunities Former President and Chief Executive Officer Bret Scholtes Resigning to Pursue Other Busines...

11 months ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023

Viactiv® Product Line Total Revenue Increased approximately 37% for the Quarter Ended March 31, 2023 as compared to the Quarter Ended March 31, 2022 Viactiv® Product Line Total Revenue Increased appro...

1 year ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022

Viactiv® Product Line Generated Net Revenues of approximately $10.6 Million or 96% of Net Revenues for the Year Ended December 31, 2022 Viactiv® Product Line Generated Net Revenues of approximately $1...

1 year ago - GlobeNewsWire

Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements

HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it has received confirmation from The Nasdaq Stock Market LLC...

1 year ago - GlobeNewsWire

Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023

HOUSTON, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced today that it will effect a 1-for-50 reverse split of its common stock ...

1 year ago - GlobeNewsWire

Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock

HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based, clinicall...

1 year ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022

Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022

1 year ago - GlobeNewsWire

Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeks

New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks

1 year ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022

Viactiv® Product Line Contributes to Highest Quarterly Revenue in Company History of Approximately $3.275 Million, Shows Significant Revenue Growth from Prior Quarter Viactiv® Product Line Contributes...

1 year ago - GlobeNewsWire

ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion's Upcoming 2022 Annual Stockholders' Meeting

HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion stock...

2 years ago - GlobeNewsWire

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide Gua...

2 years ago - GlobeNewsWire

Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon

Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon

2 years ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022 Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Re...

2 years ago - GlobeNewsWire

Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022

HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, anno...

2 years ago - GlobeNewsWire

Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store

Consumers May Now Purchase Viactiv® Omega Boost Directly from Viactiv.com

2 years ago - GlobeNewsWire

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021

June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial Results

2 years ago - GlobeNewsWire

Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference

HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, an...

2 years ago - GlobeNewsWire

Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering

HOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medica...

2 years ago - GlobeNewsWire

Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering

HOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medica...

2 years ago - GlobeNewsWire

Guardion Health Sciences Launches New Online Store for Viactiv

New e-commerce venue to offer all Viactiv products and additional educational content to enhance user experience New e-commerce venue to offer all Viactiv products and additional educational content t...

2 years ago - GlobeNewsWire